Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102 - Wikidata - wikimedia - TriplyDB

Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102

Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102

http://www.wikidata.org/entity/Q34293078

about

c-Met as a Target for Personalized Therapy The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical Aspects YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study A simple guide screw method for intracranial xenograft studies in mice.Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling.c-MET inhibition enhances the response of the colorectal cancer cells to irradiation in vitro and in vivo Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy In vitro and in vivo radiosensitization induced by hydroxyapatite nanoparticles.Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation Regenerative medicine: then and now--an update of recent history into future possibilities.MET: a promising anticancer therapeutic target.The molecular profile of microglia under the influence of glioma.Gamma histone 2AX (γ-H2AX)as a predictive tool in radiation oncology.Targeting the oncogenic Met receptor by antibodies and gene therapy.Pharmacokinetics and pharmacodynamics of rilotumumab: a decade of experience in preclinical and clinical cancer research.Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma.MET targeting: perspectives for the radiation oncologist.Trends in Malignant Glioma Monoclonal Antibody Therapy.Aggregation of lipid rafts activates c-met and c-Src in non-small cell lung cancer cells.Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib

P2860

Q26775483-035B2188-4F5D-41A8-A777-BDBF5FA72E81 Q35078950-5C9AB9D8-9F04-4391-8766-809C290973F8 Q35433475-0BEE1A78-AB02-4E5F-9647-E1B606A54246 Q35591156-0164F56A-C738-435D-9C1A-5E81E1FBB410 Q36567735-727D51F6-FFAC-4223-A379-3E69483CA508 Q36741686-54650EC3-CBC9-4B24-BE95-6472502BFBDD Q36828371-C2F341D7-5B9B-4631-8CF5-66B2D5C96602 Q36943880-F91ECF23-3FB8-4D67-831F-DBAC60B3E4C1 Q37126130-62DB1174-3A86-4080-BF3F-69770075D037 Q37295356-2104E6B6-228C-48EC-B3BE-53AD5A9BAB34 Q38008247-387E1CFB-72E9-46B4-9C1A-7EDFEC62E388 Q38008966-4BF075D3-B59A-4DFF-8E47-F91927FE4B2C Q38194616-46BC4EA0-9100-4003-8494-1B2FB36D999E Q38216590-623C1B8F-AB5D-4A93-8F24-ED9DD91992A7 Q38442573-42D618C2-ACBC-4491-A099-0F684F416494 Q39428273-DC706DC6-7F78-418D-9A80-2EA805DEE12E Q52741472-469F92E8-E247-4759-A10F-5E1D4ECCFC0B Q54942652-A514F46C-EDC4-4CEC-A366-C4E12F609A75 Q54960197-930C5057-2C74-4E19-8151-423DE5C6B34D Q58609014-F8E7B0E6-2B67-4A8C-82F5-6F67AD6E6BCE

P2860

Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102

http://www.wikidata.org/entity/Q34293078

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Radiosensitization of glioma c ...... neutralizing antibody, AMG102

@ast

Radiosensitization of glioma c ...... neutralizing antibody, AMG102

@en

Radiosensitization of glioma c ...... neutralizing antibody, AMG102

@nl

type

label

Radiosensitization of glioma c ...... neutralizing antibody, AMG102

@ast

Radiosensitization of glioma c ...... neutralizing antibody, AMG102

@en

Radiosensitization of glioma c ...... neutralizing antibody, AMG102

@nl

prefLabel

Radiosensitization of glioma c ...... neutralizing antibody, AMG102

@ast

Radiosensitization of glioma c ...... neutralizing antibody, AMG102

@en

Radiosensitization of glioma c ...... neutralizing antibody, AMG102

@nl

P1433

Q34293078-33CAE7D8-DAA8-4FAA-AAD1-A4001613463F

P1476

Q34293078-0E59FE3F-22D1-4697-80CC-45184CF28208

P2093

Q34293078-266DC347-08FA-467E-827A-5C73F5D17B36

Q34293078-61557346-3172-4AFD-8175-A15AF585A0A5

Q34293078-668EF336-DB2A-4D97-8C48-9B5E1CFC1596

Q34293078-9E414416-F147-4EF5-B8C1-35E46058C752

Q34293078-B5011026-25AE-480A-B5DF-92B6D2DB5858

Q34293078-D92B08A0-A4E0-4656-868B-3D709D9CCCC0

Q34293078-E15B3C0A-F70F-405B-84B6-9409CE82C199

P2860

Q34293078-01F04858-32CE-4BF5-9139-B8CCAD90E7FF

Q34293078-02A246DB-87F6-460C-8B4D-DF787F45235A

Q34293078-04EAA222-2332-4215-BEB6-1DBB556BAAA3

Q34293078-087D8A3D-467F-4445-B554-139850C08389

Q34293078-11E5C692-F5C6-477A-A4D5-6698A7B0E745

Q34293078-1D772260-06CD-43CE-8CC3-0BC4D83691D4

Q34293078-24540802-4C6F-4B9C-9CB3-2D023A55F384

Q34293078-24606149-32B3-4614-A032-2C1B2A82F973

Q34293078-2FC192AB-7C7A-44E6-BE6C-62D246C2DE26

Q34293078-3433B328-4FE4-407B-B7B3-C61A4465A073

P304

Q34293078-1F0957C1-F3BD-473A-8D64-E8470DD2EA9E

P31

Q34293078-FE7FF7EA-9AEF-4271-8353-E30CECA05138

P356

Q34293078-9FF3BA0C-2032-4ECF-AC21-2B8B3C8A9EDA

P433

Q34293078-4BEFD3C5-2C31-4085-B8E8-48EF0427BBCA

P478

Q34293078-6E17D85B-FDD6-4B56-AB2E-9B8C56F74007

P577

Q34293078-FD9A1B8D-23B1-4386-BF1E-10F0EE52CC26

P5875

Q34293078-5571567C-C04B-419B-A7FE-288B9CF40588

P698

Q34293078-980A410D-3EF5-4401-80F2-CC76B88DA06A

P921

Q34293078-EDBE6DE4-53A9-49D8-972F-1BFCA1E78DCD

P932

Q34293078-0E54CE15-C08C-4311-8340-D238F3B827C8

P356

J.1582-4934.2010.01122.X

P1433

Journal of Cellular and Molecular Medicine

P1476

Radiosensitization of glioma c ...... neutralizing antibody, AMG102

@en

P2093

Anita T Tandle

http://www.w3.org/2001/XMLSchema#string

Ian M Buchanan

http://www.w3.org/2001/XMLSchema#string

Kevin Camphausen

http://www.w3.org/2001/XMLSchema#string

Philip J Tofilon

http://www.w3.org/2001/XMLSchema#string

Tamalee Scott

http://www.w3.org/2001/XMLSchema#string

Teresa L Burgess

http://www.w3.org/2001/XMLSchema#string

William E Burgan

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of human hepatocyte growth factor

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

Met, metastasis, motility and more

Invasive growth: a MET-driven genetic programme for cancer and stem cells

Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors

GammaH2AX and cancer

Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.

P304

1999-2006

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1582-4934.2010.01122.X

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45187228

http://www.w3.org/2001/XMLSchema#string

P698

20629992

http://www.w3.org/2001/XMLSchema#string

P921

P932

2976812

http://www.w3.org/2001/XMLSchema#string